Search research articles
Contact Us
Filters
Showing results (81-90 of 99) with videos related to
Page
of 10
Sort By:
The American Journal of Surgical Pathology
|
May 28, 2020
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
Geert J L H van Leenders, Theodorus H van der Kwast, David J Grignon, et al.
JCO Precision Oncology
|
October 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology
Jonathan David Tward, Huei-Chung Huang, Andre Esteva, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials
Paul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 25, 2024
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2022
The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521
William A Hall, Theodore G Karrison, Seth A Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2026
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005
Kristin A Higgins, Chen Hu, Helen J Ross, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma
Emily Chan, Jesse K McKenney, Sarah Hawley, et al.
JCO Clinical Cancer Informatics
|
May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials
Mack Roach, Jingbin Zhang, Osama Mohamad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
Andrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 99) with videos related to
Sort By:
Page
of 10
The American Journal of Surgical Pathology
|
May 28, 2020
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
Geert J L H van Leenders, Theodorus H van der Kwast, David J Grignon, et al.
JCO Precision Oncology
|
October 24, 2024
Prostate Cancer Risk Stratification in NRG Oncology Phase III Randomized Trials Using Multimodal Deep Learning With Digital Histopathology
Jonathan David Tward, Huei-Chung Huang, Andre Esteva, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 3, 2023
Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials
Paul L Nguyen, Huei-Chung Rebecca Huang, Daniel E Spratt, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 25, 2024
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Correa RJM, Robertson JM, Gore EM, Doncals DE, Vigneault E, Souhami L, Karrison TG, Feng FY. Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial. Int J Radiat Oncol Biol Phys 2023;117:370-377
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 8, 2022
The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521
William A Hall, Theodore G Karrison, Seth A Rosenthal, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 3, 2023
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 13, 2026
Chemoradiation ± Atezolizumab in Limited-Stage Small Cell Lung Cancer: Results of NRG Oncology/Alliance LU005
Kristin A Higgins, Chen Hu, Helen J Ross, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
February 11, 2022
Analysis of separate training and validation radical prostatectomy cohorts identifies 0.25 mm diameter as an optimal definition for "large" cribriform prostatic adenocarcinoma
Emily Chan, Jesse K McKenney, Sarah Hawley, et al.
JCO Clinical Cancer Informatics
|
May 9, 2025
Assessing Algorithmic Fairness With a Multimodal Artificial Intelligence Model in Men of African and Non-African Origin on NRG Oncology Prostate Cancer Phase III Trials
Mack Roach, Jingbin Zhang, Osama Mohamad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 16, 2025
Development and Validation of an Artificial Intelligence Digital Pathology Biomarker to Predict Benefit of Long-Term Hormonal Therapy and Radiotherapy in Men With High-Risk Prostate Cancer Across Multiple Phase III Trials
Andrew J Armstrong, Vinnie Y T Liu, Ramprasaath R Selvaraju, et al.
Page
of 10